HDFC Bank Limited
NSE: HDFCBANK
Financial Services · Banks - Regional
Research updated
NSE: POLICYBZRFinancial ServicesInsurance Brokers
Create an account, then follow this company for weekday briefs. You will return to Pb Fintech after signing in.
Pb Fintech Ltd. is a prominent player in the financial technology sector, primarily known for operating Policybazaar, an online platform for users to compare and purchase insurance products. As a digital marketplace, it simplifies the process of selecting insurance policies by providing comprehensive comparisons based on premium, coverage, and terms from various insurers. This user-centric approach facilitates informed decisions and promotes transparency, which is pivotal in the insurance domain. Besides insurance, Pb Fintech Ltd. has expanded its offerings to include lending products and credit score evaluations, impacting sectors beyond just insurance. By leveraging technology, the company addresses a broad demographic, ranging from urban locales to underserved markets, thereby increasing financial inclusivity. Its significance in the market stems from its pioneering model that blends technology with financial services, thereby streamlining traditionally complex processes and boosting efficiency. Headquartered in India, Pb Fintech Ltd. continues to innovate within the insurtech space, helping millions of consumers and contributing to the digital transformation of the financial services industry.
Public research · Report of
PB Fintech (NSE: POLICYBZR), Online insurance and credit distribution marketplace (insurance broking, loan distribution): revenue of ₹6,794 crore in FY26 (+36.5% on FY25), an EBITDA margin of 7.5% and net profit of ₹669.9 crore.
PB Fintech runs Policybazaar, India's largest online insurance marketplace (FY26 insurance premium INR 29,934 cr, issuer-estimated 18-20% of fresh retail health and ~25% of fresh term insurance), and Paisabazaar, an online credit marketplace (FY26 disbursals INR 30,740 cr). It earns commissions and service fees from insurers and lenders, plus renewal trail revenue; new initiatives include PB Partners (agent platform), PB for Business, PB UAE and PB Connect. It has no borrowings and holds a large treasury from its 2021 IPO.
| Item | Value |
|---|---|
| Legal name | PB Fintech Limited (formerly Etechaces Marketing and Consulting Private Limited) |
| Exchange and ticker | NSE: POLICYBZR; BSE: 543390 |
| ISIN | INE417T01026 |
| CIN | L51909HR2008PLC037998 |
| Sector | Financial Services |
| Industry | Online insurance and credit distribution marketplace (insurance broking, loan distribution) |
| Headquarters | Gurugram, India |
| Fiscal year end | March |
| Reporting basis and unit | consolidated, in ₹ crore |
| Auditor | Walker Chandiok & Co LLP |
| Market capitalisation | ₹83,409 crore (13 Oct 2026) |
| Shares outstanding | 46.33 crore shares (FY26) |
| Price | ₹1,047 (close, 13 Oct 2026) |
| 52-week range | ₹945.1 - ₹1,964 (to 13 Oct 2026) |
| Website | https://www.pbfintech.in |
| Entity | Holding | Business |
|---|---|---|
| Policybazaar Insurance Brokers Private Limited | 100% | Composite insurance broker (IRDAI licence); online insurance marketplace, PB Partners agent platform, PB for Business |
| Paisabazaar Marketing and Consulting Private Limited | 100% | Online consumer credit marketplace; loan and card distribution, credit scores, mutual funds |
| PB Healthcare Services Private Limited | 28.46% | Associate (equity method) since 24 Apr 2025; hospital network venture; PB Fintech invested INR 539.4 cr |
| YKNP Marketing Management LLC | 26.72% | Indirect associate (UAE) |
| MyLoancare Ventures Private Limited | 80% | RBI-registered NBFC, loan aggregation; in-principle approval (16 Sep 2026) to buy remaining 20% for up to INR 5 cr |
Directors' Report lists 16 subsidiaries and 7 associates; only material ones listed. No identifiable promoter: professionally managed, founders hold shares in the public category.
| Shareholding (% of shares) | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoter | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign institutions | 43.60% | 40.80% | 39.94% | 37.30% |
| Domestic institutions | 26.60% | 29.50% | 36.73% | 40.40% |
| of which mutual funds | 18.13% | 20.21% | 25.94% | 28.32% |
| Retail | 2.69% | 2.63% | 2.75% | 2.64% |
| Other | 20.58% |
The promoter holding pledged is a share of the promoter's own holding.
PB Fintech is an insurance/credit distributor, not an underwriter or balance-sheet lender. Policybazaar monetises acquisition and servicing through insurer commission; Paisabazaar distributes credit; New Initiatives include PB Partners, PB for Business, UAE and PB Connect. Advertising builds the funnel, employees advise and service, while renewals amortise acquisition expense. Control is over user journey and distribution, not regulated commission caps or lender risk appetite. PBHealth is an associate (28.46%), not consolidated hospital sales.
| Segment | revenue, FY26 (₹ crore) | Share | contribution, FY26 (₹ crore) | Share | adjusted ebitda, FY26 (₹ crore) | Share |
|---|---|---|---|---|---|---|
| Core Online: Policybazaar and Paisabazaar (management) | 4,079 | 30.0% | 1,814 | 92.8% | 841.0 | 116.0% |
| New Initiatives incl PBPartners, corporate, UAE, PBConnect | 2,715 | 20.0% | 140.0 | 7.2% | -116.0 | -16.0% |
| Insurance Broker services (consolidated statutory Ind AS108) | 6,089 | 44.8% | ||||
| Other services (consolidated statutory Ind AS108) | 704.7 | 5.2% |
Segments as the company reports them (consolidated); each share is of the segments' sum.
| Peer | Why the dossier compares them |
|---|---|
| Turtlemint Fintech Solutions | Only other listed Indian insurance distribution platform (listed June 2026); same IRDAI commission exposure |
| Info Edge (India) (NAUKRI) | Listed consumer internet marketplace, also PB Fintech's largest shareholder; comparable asset-light platform economics |
| Zomato (Eternal) (ETERNAL) | |
| One 97 Communications (Paytm) (PAYTM) | Listed fintech distributing credit and insurance; regulator-set economics |
| Medi Assist Healthcare Services (MEDIASSIST) | Listed health insurance services intermediary (TPA) dependent on insurer payouts |
| Star Health and Allied Insurance (STARHEALTH) | Largest standalone retail health insurer; the counterparty side of the commission economics |
| Profit and loss (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | 1,425 | 2,558 | 3,438 | 4,977 | 6,794 |
| Cost of revenue (vendor classification) * | 1,256 | 987.5 | 1,954 | 2,944 | 4,026 |
| Other operating costs (vendor classification) * | 1,002 | 1,610 | 1,232 | 1,584 | 1,825 |
| EBITDA (vendor classification) * | -707.5 | -438.1 | 155.2 | 447.5 | 838.4 |
| Operating EBIT excluding other income | -750.3 | -466.6 | -275.0 | -28.6 | 373.3 |
| Finance costs | 83.1 | 21.4 | 26.5 | 33.8 | 37.1 |
| Profit before tax after associates and exceptional | -833.4 | -488.0 | 77.1 | 386.7 | 707.4 |
| Total income tax expense | -0.48 | -0.02 | 12.7 | 34.5 | 37.2 |
| Profit after tax including NCI | -832.9 | -487.9 | 64.4 | 352.2 | 670.1 |
| Diluted EPS INR per share | -20.34 | -10.97 | 1.45 | 7.63 | 14.46 |
| Employee benefits including SBC | 1,644 | 1,959 | 2,466 | ||
| Advertising and promotion expense | 899.0 | 1,090 | 1,213 | ||
| Network and internet expense | 114.8 | 139.1 | 196.5 | ||
| Other expenses statutory row | 966.0 | 1,697 | 2,410 | ||
| Advertising plus network plus other expenses | 1,980 | 2,926 | 3,819 | ||
| Materials/traded goods cost not applicable | 0.00 | 0.00 | 0.00 | ||
| Operating EBITDA including SBC excluding other income | -186.3 | 92.7 | 509.2 | ||
| Other income | 380.6 | 407.8 | 372.4 | ||
| Depreciation and amortisation | 88.7 | 121.3 | 136.0 | ||
| Share of associate profit or loss signed | -2.02 | 0.26 | -1.24 | ||
| Exceptional gain or loss signed | 0.00 | 41.1 | 0.00 | ||
| PAT attributable to noncontrolling interests signed | -2.57 | 0.15 | 0.19 | ||
| PAT attributable to owners | 67.0 | 352.1 | 669.9 |
| Balance sheet (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Total equity including NCI | 5,412 | 5,485 | 5,876 | 6,438 | 7,318 |
| Non-lease borrowings | 159.4 | 226.6 | n.r. | n.r. | 0.00 |
| Cash and cash equivalents | 367.4 | 72.3 | 324.9 | 560.5 | 746.3 |
| Total current plus noncurrent trade receivables | 360.9 | 677.3 | 650.5 | 1,115 | 1,968 |
| Trade payables micro small plus other | 198.2 | 306.1 | 301.1 | 367.8 | 471.1 |
| Net property, plant and equipment * | 180.1 | 269.8 | 315.4 | 411.1 | 430.4 |
| Capital work in progress * | 0.28 | 0.26 | 0.20 | 6.56 | |
| Total assets | 5,915 | 6,254 | 6,729 | 7,531 | 8,707 |
| Bank balances other than cash equivalents | 410.1 | 232.6 | 13.6 | ||
| Current investments | 423.6 | 640.0 | 1,356 | ||
| Noncurrent financial investments excluding equity method | n.r. | 1,518 | 1,302 | ||
| Investments accounted for by equity method | n.r. | 15.0 | 553.2 | ||
| Current other financial assets not assumed all liquid | 2,957 | 1,334 | 436.0 | ||
| Noncurrent other financial assets | 291.3 | 1,179 | 430.5 | ||
| Current trade receivables | 634.1 | 999.6 | 1,729 | ||
| Noncurrent trade receivables | 16.4 | 115.5 | 239.0 | ||
| Current lease liabilities | 34.8 | 46.7 | 55.4 | ||
| Noncurrent lease liabilities | 214.1 | 275.6 | 304.8 | ||
| Total lease liabilities | 248.9 | 322.2 | 360.2 | ||
| Company-defined net debt including eligible investments | n.r. | n.r. | n.r. | ||
| Noncurrent investments including associates (old basis) | 934.9 | ||||
| Total receivables/annualsales x365 (days) | 69 | 82 | 106 | ||
| Receivable YoYgrowth lesssales growth (%) | 26.6% | 40.0% |
| Cash flow (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Net cash from operating activities after taxes | -1,675 | -397.5 | 8.65 | -183.2 | 41.5 |
| Free cash flow (vendor definition) * | -1,601 | -364.7 | -54.7 | -280.3 | -38.4 |
| Cash PPE and intangible capex (outflow magnitude) | -29.8 | -63.9 | 63.4 | 97.1 | 79.9 |
| Gross cash paid for business combinations | n.r. | 9.03 | n.r. | ||
| Cash paid for investments in associates | 539.4 | ||||
| Lease principal cash payments | 31.2 | 41.0 | 47.1 | ||
| Lease interest cash payments | 26.0 | 33.2 | 36.8 | ||
| Cash proceeds from issue of equity shares | 0.22 | 8.21 | 20.0 | ||
| CFO less positive cash PPE and intangible capex | -54.7 | -280.4 | -38.4 | ||
| CFO after cash tax / total PAT incl NCI | 0.13x | -0.52x | 0.06x | ||
| Trailing three-year cumulative CFO/PAT incl NCI (x) | -0.12x |
| Other reported lines (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Approximate weighted diluted shares not period-end issued shares | 40.95 | 44.49 | 46.19 | 46.14 | 46.33 |
| Employee SBC included in expense not an addback | n.r. | 213.7 | 194.2 | ||
| Management headline cash unspecified composition and basis | 5,263 | 5,406 | n.r. |
| Quarterly profit and loss (₹ crore) | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 1,167 | 1,292 | 1,508 | 1,348 | 1,614 | 1,771 | 2,061 | 1,888 |
| Cost of revenue (vendor classification) * | 507.6 | 487.4 | 1,493 | 559.9 | 606.7 | 699.3 | 715.7 | |
| Other operating costs (vendor classification) * | 667.5 | 776.5 | -454.7 | 753.7 | 1,006 | 1,144 | 1,033 | |
| EBITDA (vendor classification) * | 98.6 | 128.0 | 175.3 | 134.6 | 244.1 | 316.6 | 229.8 | |
| Operating EBIT excluding other income | -37.2 | -5.95 | 78.8 | 0.90 | 64.0 | 125.0 | 183.4 | 99.2 |
| Finance costs | 8.98 | 9.31 | 9.17 | 8.77 | 9.23 | 9.31 | 9.78 | 11.1 |
| PBT after associates and exceptional items | 60.3 | 85.1 | 170.5 | 92.3 | 142.1 | 201.1 | 271.9 | 178.6 |
| Total income tax expense | 9.28 | 13.6 | 0.78 | 7.69 | 7.17 | 11.6 | 10.7 | 15.7 |
| Profit after tax including NCI | 51.0 | 71.5 | 169.7 | 84.7 | 134.9 | 189.4 | 261.2 | 162.9 |
| Diluted EPS INR per share | 1.09 | 1.55 | 3.65 | 1.82 | 2.89 | 4.08 | 5.61 | 3.50 |
| Employee benefits including SBC | 507.6 | 487.4 | 508.2 | 559.9 | 600.0 | 606.7 | 699.3 | 715.7 |
| Advertising and promotion | 278.0 | 289.5 | 277.4 | 253.2 | 280.1 | 308.6 | 370.8 | 379.1 |
| Network and internet | 34.2 | 36.9 | 36.4 | 42.6 | 43.1 | 53.2 | 57.6 | 56.7 |
| Other expenses statutory row | 355.2 | 450.2 | 573.8 | 458.0 | 592.5 | 643.9 | 715.4 | 597.4 |
| Advertising plus network plus other expense | 667.5 | 776.6 | 887.6 | 753.8 | 915.7 | 1,006 | 1,144 | 1,033 |
| Operating EBITDA including SBC excluding other income | -7.80 | 27.6 | 112.1 | 34.4 | 97.8 | 158.8 | 218.3 | 139.3 |
| Materials/traded goods cost not applicable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other income | 106.0 | 100.4 | 101.1 | 98.8 | 84.5 | 84.9 | 104.3 | 93.0 |
| Depreciation and amortisation | 29.4 | 33.6 | 33.3 | 33.5 | 33.9 | 33.8 | 34.9 | 40.1 |
| Share of associate profit or loss signed | 0.41 | -0.06 | -0.22 | 1.45 | 2.82 | 0.51 | -6.02 | -2.48 |
| Exceptional gain or loss signed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT attributable to NCI signed | 0.31 | 0.00 | 0.04 | 0.06 | 0.03 | 0.05 | 0.05 | 0.02 |
| PAT attributable to owners | 50.7 | 71.5 | 169.7 | 84.6 | 134.9 | 189.4 | 261.1 | 162.9 |
Consolidated, as reported. Lines marked * are the market-data provider's figures; the rest are extracted from the company's filings or derived from them. n.d. not disclosed, n.r. not retrieved, n.a. not applicable.
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue growth | 60.7% | 79.5% | 34.4% | 44.8% | 36.5% |
| EBITDA margin | -5.4% | 1.9% | 7.5% | ||
| Net margin | 1.9% | 7.1% | 9.9% | ||
| Return on equity | 1.2% | 5.7% | 9.7% | ||
| Return on capital employed | -19.6% | -8.3% | 5.1% | ||
| Return on assets | 1.0% | 4.9% | 8.3% | ||
| Borrowings less cash (₹ crore) | -208.0 | 154.3 | -746.3 | ||
| Borrowings less cash / EBITDA | -1.47x | ||||
| Interest cover | -9.03x | -21.8x | -10.4x | -0.85x | 10.1x |
| Asset turnover | 0.35x | 0.42x | 0.53x | 0.70x | 0.84x |
| Receivable days | 92 | 97 | 69 | 82 | 106 |
| Payable days (on revenue) | 51 | 44 | 32 | 27 | 25 |
| Cash conversion | 0.13x | -0.52x | 0.06x | ||
| Capex intensity | 2.1% | 2.5% | 1.8% | 2.0% | 1.2% |
| Free cash flow (₹ crore) | -1,705 | -461.4 | -54.7 | -280.4 | -38.4 |
| EPS, diluted (₹) | -20.34 | -10.97 | 1.45 | 7.63 | 14.46 |
| Book value per share (₹) | 132.2 | 123.3 | 127.2 | 139.5 | 157.9 |
Computed from the statements above:
Source: the company's filings and disclosures as extracted into Mool's company dossier (version 1, information to 13 Oct 2026); market data at the close of 13 Oct 2026. Every figure is read from the dossier's files or computed from them; the account of the business model is the analyst's, from the dossier's workings.
With Individual or above
Every piece of Mool’s research is built the same way: a researched evidence base, analyses that build on each other, a research model and a report with the call. This page shows the first analysis.
The model behind the report: the company’s history, the drivers that move it, its forecasts by scenario and the valuation the 12-month target comes from.
Individual or above opens every piece of research Mool has published. A new account can start with 10 days of Pro, or of Firm on a work email address. No card needed.
Report history
Same sector
NSE: HDFCBANK
Financial Services · Banks - Regional
Research updated
NSE: ICICIBANK
Financial Services · Banks - Regional
Research updated
NSE: SBIN
Financial Services · Banks - Regional
Research updated
NSE: BAJFINANCE
Financial Services · Credit Services
Research updated
NSE: LICI
Financial Services · Insurance - Life
Research updated
NSE: KOTAKBANK
Financial Services · Banks - Regional
Research updated
Prices are the last close on the NSE, 23 Oct 2026. Research from Mool’s report of 13 Oct 2026; page updated 25 Oct 2026.
Mool’s research is written by AI agents and published by Mool Capital Private Limited, a SEBI-registered Research Analyst, registration INH000012449, which is responsible for it. This page shows factual company information and an excerpt of that research; it carries no rating and is not investment advice for any individual. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Read the disclosures.